US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 99.970
  • -0.060-0.06%
Close Jan 24 16:00 ET
  • 99.970
  • 0.0000.00%
Post 20:01 ET
199.87BMarket Cap11.73P/E (TTM)

About Novartis AG Company

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Company Profile

SymbolNVS
Company NameNovartis AG
Listing DateMay 11, 2000
Founded1996
CEOMr. Vasant Narasimhan
MarketNYSE
Employees76057
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLichtstrasse 35
CityBasel
ProvinceBasel-Stadt (Basle Town)
CountrySwitzerland
Zip Code4056
Phone41-61-324-11-11

Company Executives

  • Name
  • Position
  • Salary
  • Vasant Narasimhan
  • Chief Executive Officer
  • 13.27M
  • Karen L. Hale
  • Chief Legal Officer
  • --
  • Aharon Gal, PhD
  • Chief Strategy and Growth Officer
  • --
  • Dr. Shreeram Aradhye, M.D.
  • President, Development and Chief Medical Officer
  • --
  • Harry Kirsch
  • Chief Financial Officer
  • 6.53M
  • Robert Kowalski
  • Chief People and Organization Officer
  • --
  • Klaus Moosmayer
  • Chief Ethics, Risk and Compliance Officer
  • --
  • Dr. Steffen Lang, PhD
  • President, Operations
  • --
  • Simon Moroney, D.Phil.
  • Vice Chairman of the Board
  • 460.00K
  • Victor Bulto
  • President, US
  • 5.16M
  • Joerg Reinhardt, PhD
  • Chairman of the Board
  • 3.80M
  • Fiona Marshall, PhD
  • President, Biomedical Research
  • --
  • Patrick Horber
  • President, International
  • 6.68M
  • Ton Buechner
  • Independent Director
  • 424.68K
  • John Douglas Young
  • Independent Director
  • 304.68K
  • Elizabeth Doherty
  • Independent Director
  • 450.00K
  • Dr. Charles L. Sawyers
  • Independent Director
  • 360.00K
  • Bridgette P. Heller
  • Independent Director
  • 430.00K
  • Frans Van Houten
  • Independent Director
  • 394.68K
  • William Thomas Winters
  • Independent Director
  • 360.00K
  • Daniel Hochstrasser
  • Independent Director
  • 376.34K
  • Ana de Pro Gonzalo
  • Independent Director
  • 390.00K
  • Patrice Bula
  • Lead Independent Director
  • 413.78K
  • Dr. Nancy C. Andrews, M.D.,PhD
  • Independent Director
  • 360.00K

Trending Stocks

Discussing
As Tesla's earnings near, will its stock soar?
🎙️Discussion: 1. With Trump's return, can Tesla's stock price continue to rise in 2025? 2. Tesla is set to release its earnings report aft Show More